Erlotinib in combination with pemetrexed for patients with advanced non-small-cell lung cancer (NSCLC): a phase I dose-finding study.

Source:http://linkedlifedata.com/resource/pubmed/id/20444843

Download in:

View as

General Info

PMID
20444843